Cell Lysis/Cell Fractionation Market Research Report 2022 – Global Forecast to 2027: Growing Focus on Personalized Medicine, and the Expansion of Biopharmaceutical and Biotechnology Industries – ResearchAndMarkets.com

Cell Lysis/Cell Fractionation Market Research Report 2022 – Global Forecast to 2027: Growing Focus on Personalized Medicine, and the Expansion of Biopharmaceutical and Biotechnology Industries – ResearchAndMarkets.com

Cell Lysis/Cell Fractionation Market Research Report 2022 – Global Forecast to 2027: Growing Focus on Personalized Medicine, and the Expansion of Biopharmaceutical and Biotechnology Industries – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Cell Lysis/Cell Fractionation Market Research Report by Product (Consumables and Instruments), Cell Type, Application, End-user, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering.

The Global Cell Lysis/Cell Fractionation Market size was estimated at USD 2,857.61 million in 2021, USD 3,094.01 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 8.44% to reach USD 4,649.13 million by 2027.

In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Cumulative Impact of COVID-19:

The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects.

It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cell Lysis/Cell Fractionation Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space.

It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors.

The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

  • Agilent Technologies
  • Beckman Coulter
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories
  • Biovision
  • Cell Signaling Technology
  • Claremont Biosolutions
  • Covaris
  • G-Biosciences (Geno Technology)
  • Labfreez Instruments Group
  • Merck
  • Microfluidics International Corporation
  • Miltenyi Biotec
  • Norgen Biotek Corp.
  • Nzytech
  • Parr Instrument Company
  • Promega Corporation
  • Promocell
  • Qiagen
  • Qsonica
  • Roche Diagnostics
  • Stemcell Technologies
  • Takara Bio
  • Thermo Fisher Scientific

Key Topics Covered:

1. Preface

1.1. Objectives of the Study

1.2. Market Segmentation & Coverage

1.3. Years Considered for the Study

1.4. Currency & Pricing

1.5. Language

1.6. Limitations

1.7. Assumptions

1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective

2.2. Determine: Research Design

2.3. Prepare: Research Instrument

2.4. Collect: Data Source

2.5. Analyze: Data Interpretation

2.6. Formulate: Data Verification

2.7. Publish: Research Report

2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics

5.1.1. Drivers Expanding healthcare, life sciences, and pharmaceutical industries research and developmental activities in countless fields Increasing government funding for research Increasing cases of diseases and diagnostics

5.1.2. Restraints High cost of cell-based equipments and researches Shortage of trained personnel

5.1.3. Opportunities Growing focus on personalized medicine, and the expansion of biopharmaceutical and biotechnology industries Growing prevalence of diseases such as HIV/AIDS and cancer

5.1.4. Challenges Survival of small players and addition of new technological advancement routinely

5.2. Cumulative Impact of COVID-19

5.3. Cumulative Impact of 2022 Russia Ukraine Conflict

6. Cell Lysis/Cell Fractionation Market, by Product

6.1. Introduction

6.2. Consumables

6.2.1. Beads

6.2.2. Disposables

6.2.3. Reagents & Kits

6.3. Instruments

6.3.1. Homogenizers

6.3.2. Sonicators

7. Cell Lysis/Cell Fractionation Market, by Cell Type

7.1. Introduction

7.2. Mammalian Cells

7.3. Microbial Cells

8. Cell Lysis/Cell Fractionation Market, by Application

8.1. Introduction

8.2. Nucleic Acid Purification & Isolation

8.3. Protein Purification & Isolation

9. Cell Lysis/Cell Fractionation Market, by End-user

9.1. Introduction

9.2. Biopharmaceutical & Biotechnology Companies

9.3. Research Laboratories & Institutes

10. Americas Cell Lysis/Cell Fractionation Market

10.1. Introduction

10.2. Argentina

10.3. Brazil

10.4. Canada

10.5. Mexico

10.6. United States

11. Asia-Pacific Cell Lysis/Cell Fractionation Market

11.1. Introduction

11.2. Australia

11.3. China

11.4. India

11.5. Indonesia

11.6. Japan

11.7. Malaysia

11.8. Philippines

11.9. Singapore

11.10. South Korea

11.11. Taiwan

11.12. Thailand

12. Europe, Middle East & Africa Cell Lysis/Cell Fractionation Market

12.1. Introduction

12.2. France

12.3. Germany

12.4. Italy

12.5. Netherlands

12.6. Qatar

12.7. Russia

12.8. Saudi Arabia

12.9. South Africa

12.10. Spain

12.11. United Arab Emirates

12.12. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix

13.1.1. Quadrants

13.1.2. Business Strategy

13.1.3. Product Satisfaction

13.2. Market Ranking Analysis

13.3. Market Share Analysis, By Key Player

13.4. Competitive Scenario

13.4.1. Merger & Acquisition

13.4.2. Agreement, Collaboration, & Partnership

13.4.3. New Product Launch & Enhancement

13.4.4. Investment & Funding

13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles

For more information about this report visit https://www.researchandmarkets.com/r/4vd7q5



Laura Wood, Senior Press Manager

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900